Robin MacGregor Murray

Sir Robin MacGregor Murray is Professor of Psychiatric Research at the Institute of Psychiatry, King's College London, and an Honorary Consultant at South London and Maudsley NHS Foundation Trust. He serves as co-editor-in-chief of Psychological Medicine and previously served as President of the European Psychiatric Association. His career spans over five decades with significant contributions to understanding the causes and treatments of psychotic disorders.

His educational background includes:

• Doctor of Science in Research in Schizophrenia, University of London (1988)
• Master of Philosophy in Psychiatric Illness in Doctors, University of London (1976)
• Doctor of Medicine in Analgesic Nephropathy, University of Glasgow (1974)
• Bachelor of Medicine, University of Glasgow (1968)

Murray's research primarily focuses on schizophrenia and bipolar disorder, with particular emphasis on neurodevelopmental aspects of psychosis, environmental risk factors including cannabis use, and developing better treatments for psychotic illnesses. He pioneered research demonstrating that prolonged heavy cannabis use can contribute to psychosis onset, especially when initiated before age 15 or with high-potency varieties. His work integrates clinical practice with research through the National Psychosis Unit where he cares for patients with treatment-resistant psychosis.

Analysis of his recent publications reveals consistent focus on gene-environment interactions in psychosis, cognitive aspects of psychotic disorders, and the biological mechanisms underlying schizophrenia. His research increasingly incorporates international collaborations examining psychosis across diverse populations and settings.

His scientific honors include:

• Fellow of the Royal Society (elected 2010)
• Fellow of the Royal College of Psychiatrists
• Knighthood in the 2011 New Year Honours for services to medicine
• Ranking among the most influential researchers in Psychiatry by Thomson Reuters' Science Watch
• 3rd ranking globally in Schizophrenia Research

Murray has supervised 82 PhDs and 5 MD Theses with 100% success rate and currently leads multiple major research projects including the Cannabis Clinic for Psychosis intervention study, the INTREPID III international psychosis research program, and the YOUTH GEMs project examining gene-environment interactions in youth mental health. His research has been supported by substantial funding from organizations including the MRC Medical Research Council, Maudsley Charity, and Technology Strategy Board.

He leads The Psychosis Research Group at the Institute of Psychiatry, one of the largest psychosis research groups globally by publication output, and works clinically within the National Psychosis Unit at the South London and Maudsley NHS Trust, which serves patients with psychotic illnesses from across the UK.